Healthcare provider profile · identity verified

Gerald George Rossman, MD

Internal Medicine · PITTSBURGH, PA · NPI 1497736649

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	555	163
Levothyroxine Sodium	Levothyroxine Sodium	396	107
Amlodipine Besylate	Amlodipine Besylate	364	97
Pantoprazole Sodium	Pantoprazole Sodium	276	90
Rosuvastatin Calcium	Rosuvastatin Calcium	258	79
Furosemide	Furosemide	255	67
Metoprolol Succinate	Metoprolol Succinate	202	54
Valsartan	Valsartan	199	51
Omeprazole	Omeprazole	196	62
Lisinopril	Lisinopril	176	50
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	161	37
Eliquis	Apixaban	158	34
Gabapentin	Gabapentin	148	33
Famotidine	Famotidine	141	36
Synthroid	Levothyroxine Sodium	141	38
Metformin Hcl	Metformin Hcl	136	34
Escitalopram Oxalate	Escitalopram Oxalate	135	34
Trazodone Hcl	Trazodone Hcl	124	27
Mirtazapine	Mirtazapine	121	21
Potassium Chloride	Potassium Chloride	102	28
Losartan Potassium	Losartan Potassium	98	32
Metformin Hcl Er	Metformin Hcl	96	28
Simvastatin	Simvastatin	94	29
Prednisone	Prednisone	93	44
Tamsulosin Hcl	Tamsulosin Hcl	93	25
Montelukast Sodium	Montelukast Sodium	87	28
Atenolol	Atenolol	84	27
Tramadol Hcl	Tramadol Hcl	84	25
Irbesartan	Irbesartan	83	22
Donepezil Hcl	Donepezil Hcl	80	16
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	79	57
Baclofen	Baclofen	76	30
Ozempic	Semaglutide	76	18
Carvedilol	Carvedilol	75	18
Lorazepam	Lorazepam	72	22
Hydrochlorothiazide	Hydrochlorothiazide	70	22
Albuterol Sulfate Hfa	Albuterol Sulfate	66	32
Terazosin Hcl	Terazosin Hcl	63	12
Fluoxetine Hcl	Fluoxetine Hcl	62	12
Meloxicam	Meloxicam	62	25
Celecoxib	Celecoxib	56	16
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	56	13
Cephalexin	Cephalexin	55	41
Glimepiride	Glimepiride	53	16
Mounjaro	Tirzepatide	52	suppressed
Pravastatin Sodium	Pravastatin Sodium	50	16
Clonazepam	Clonazepam	48	suppressed
Glipizide	Glipizide	47	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	47	14
Duloxetine Hcl	Duloxetine Hcl	45	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	44	suppressed
Allopurinol	Allopurinol	43	14
Alprazolam	Alprazolam	43	suppressed
Sertraline Hcl	Sertraline Hcl	43	14
Januvia	Sitagliptin Phosphate	42	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	42	32
Alendronate Sodium	Alendronate Sodium	41	suppressed
Buspirone Hcl	Buspirone Hcl	36	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	36	suppressed
Spironolactone	Spironolactone	36	suppressed
Xarelto	Rivaroxaban	34	suppressed
Jardiance	Empagliflozin	32	suppressed
Methylprednisolone	Methylprednisolone	32	28
Esomeprazole Magnesium	Esomeprazole Magnesium	30	suppressed
Ezetimibe	Ezetimibe	30	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	30	15
Citalopram Hbr	Citalopram Hydrobromide	29	suppressed
Ibandronate Sodium	Ibandronate Sodium	29	suppressed
Risedronate Sodium	Risedronate Sodium	29	suppressed
Warfarin Sodium	Warfarin Sodium	29	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	29	11
Ipratropium Bromide	Ipratropium Bromide	28	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	28	suppressed
Breo Ellipta	Fluticasone/Vilanterol	27	suppressed
Clopidogrel	Clopidogrel Bisulfate	27	suppressed
Digoxin	Digoxin	27	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	26	suppressed
Finasteride	Finasteride	25	suppressed
Fluticasone Propionate	Fluticasone Propionate	25	12
Paroxetine Hcl	Paroxetine Hcl	25	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	24	22
Clonidine Hcl	Clonidine Hcl	23	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	23	suppressed
Meclizine Hcl	Meclizine Hcl	23	13
Memantine Hcl	Memantine Hcl	23	suppressed
Bumetanide	Bumetanide	22	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	22	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	22	suppressed
Ondansetron Hcl	Ondansetron Hcl	21	12
Bupropion Xl	Bupropion Hcl	20	suppressed
Repaglinide	Repaglinide	20	suppressed
Amoxicillin	Amoxicillin	18	14
Ibuprofen	Ibuprofen	18	suppressed
Ketoconazole	Ketoconazole	18	12
Azithromycin	Azithromycin	16	14
Levetiracetam	Levetiracetam	16	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	16	suppressed
Trulicity	Dulaglutide	16	suppressed
Benazepril Hcl	Benazepril Hcl	15	suppressed
Etodolac	Etodolac	15	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Prolia	Denosumab	15	suppressed
Propranolol Hcl Er	Propranolol Hcl	15	suppressed
Verapamil Er	Verapamil Hcl	15	suppressed
Aripiprazole	Aripiprazole	14	suppressed
Enalapril Maleate	Enalapril Maleate	14	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	14	suppressed
Cartia Xt	Diltiazem Hcl	13	suppressed
Glipizide Er	Glipizide	13	suppressed
Hydrocortisone	Hydrocortisone	13	suppressed
Gemtesa	Vibegron	12	suppressed
Valacyclovir	Valacyclovir Hcl	12	suppressed
Fluconazole	Fluconazole	11	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	11	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	11	suppressed
Probenecid	Probenecid	11	suppressed
Propranolol Hcl	Propranolol Hcl	11	suppressed
Raloxifene Hcl	Raloxifene Hcl	11	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error